Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

22/02/2017
Remploy will cut its hourly pay rate for ‘experts by experience’ employed by the Care Quality Commission by nearly 20%, from 1 April.
22/02/2017
Advanced Oncotherapy has secured a £26 million financing agreement with Bracknor Investment.
21/02/2017
NHS providers reported a combined £886 million year-to-date deficit in the third quarter of 2016-2017.
21/02/2017
Nearly two thirds of England could see hospital services cut when sustainability and transformation plans are implemented, recent analysis has shown.
21/02/2017
Stirling Square Capital Partners’s offer to dispose of parts of Acorn Care & Education to address competition concerns "might be acceptable", the Competition & Markets Authority has said.


Alix Partners




Valentina Petrone tells Ploy Radford how The Private Clinic has distanced itself from the cosmetic surgery market's image problem and turned its woes to its advantage
Read more...


What does BC Partners' creation of a new mental health platform mean for the sector, asks Peter Cunliffe
Read more...
HealthInvestor Events

Circumstances dictate that more care homes need to be built, but it's a far from easy task for providers. Ploy Radford examines the state of England's care home development pipeline
Read more...


Christie + Co

Is the Competition & Markets Authority's decision to investigate the elderly care market the right move?
Read more...



HealthInvestor blog
The government’s latest housing white paper has pleasingly recognised the importance of housing with care, but it’s far from a panacea for the market’s problems

Click here to view the Editor's blog


National head of business development – healthcare and education at Santander and London College of Fashion graduate
The courts, local authorities and employers are driving up the demand for drug and alcohol testing, meaning a pleasant high for test providers, find Clare Connell and Charlotte Bushnell of Connell Consulting
Candesic’s Dr Joe Taylor and Kate Hall consider the role physiotherapy can play in addressing the amassing challenges of health and social care faced by an ageing UK
Private providers, and Virgin Care in particular, are trying to conquer more of the community care space. But is it worth it, asks David Waller
Circumstances dictate that more care homes need to be built, but it’s a far from easy task for providers. Ploy Radford examines the state of England’s care home development pipeline

Click here to search all feature articles